| Aug 2 |
Cerus Corporation (CERS) Q2 2024 Earnings Call Transcript
|
| Aug 1 |
Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 1 |
Cerus GAAP EPS of -$0.03 beats by $0.01, revenue of $50.5M beats by $7.99M
|
| Aug 1 |
Cerus: Q2 Earnings Snapshot
|
| Aug 1 |
Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range
|
| Jul 31 |
Cerus Q2 2024 Earnings Preview
|
| Jul 18 |
Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024
|
| Jul 2 |
Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors
|
| Jun 21 |
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
|
| Jun 16 |
Cerus (NASDAQ:CERS) shareholders have endured a 70% loss from investing in the stock three years ago
|
